Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yan Wang
Observed names:
Y Wang,
Yun Wang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
National Medical Products Administration
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
National Medical Products Administration
ORCID:
0009-0002-6613-3984
Observed ORCID:
0009-0002-6613-3984
OpenAlex ID:
A5036896379
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling
2016
·
CH Li
, RR Bies
, et al.
·
Clinical and Translational Science
·
13
PDF
MIDD Evidence to Support Drug Regulatory Decisions in China
2026
·
Lili Gao
, Yan Wang
, et al.
·
Clinical and Translational Science
·
1
Decoding Oligonucleotide Stereochemistry: Individual Phosphorothioate Configuration Ratios and Intact Sequence Diastereomeric Composition
2026
·
Md Rabiul Islam
, Leonard Yoon
, et al.
·
Analytical Chemistry
·
1
Optimizing Oligonucleotide Therapeutics: A Model‐Informed Drug Development Perspective
2026
·
Ye Yuan
, Vishnu Sharma
, et al.
·
Clinical and Translational Science
·
1
API particle size governs in situ forming implant formation, microstructure evolution and performance
2026
·
McKenzie Roy
, Xiaoyi Wang
, et al.
·
International Journal of Pharmaceutics
Show more works
View as search
Works count:
5
Citation count:
16
H-index:
1
I10-index:
1
Year
Topic
Type